INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 103 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $126,000 | -43.0% | 27,351 | +24.7% | 0.00% | – |
| Q3 2018 | $221,000 | +54.5% | 21,940 | +10.7% | 0.00% | – |
| Q2 2018 | $143,000 | +21.2% | 19,811 | +1.6% | 0.00% | – |
| Q1 2018 | $118,000 | -30.6% | 19,493 | +10.3% | 0.00% | – |
| Q4 2017 | $170,000 | -60.1% | 17,678 | -47.6% | 0.00% | -100.0% |
| Q2 2017 | $426,000 | +57.8% | 33,712 | +31.1% | 0.00% | – |
| Q1 2017 | $270,000 | +53.4% | 25,712 | +34.5% | 0.00% | – |
| Q4 2016 | $176,000 | +20.5% | 19,112 | +54.2% | 0.00% | – |
| Q3 2016 | $146,000 | -25.9% | 12,394 | -18.4% | 0.00% | – |
| Q2 2016 | $197,000 | -4.4% | 15,197 | +18.1% | 0.00% | – |
| Q1 2016 | $206,000 | -83.1% | 12,869 | -69.7% | 0.00% | -100.0% |
| Q4 2015 | $1,216,000 | – | 42,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,257,094 | $92,697,000 | 13.04% |
| JW Asset Management, LLC | 388,346 | $11,052,000 | 4.00% |
| Anson Funds Management LP | 400,200 | $11,390,000 | 3.31% |
| Orbimed Advisors | 4,081,800 | $116,168,000 | 1.17% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,718,487 | $48,908,000 | 1.05% |
| Bellevue Asset Management AG | 210,000 | $5,977,000 | 0.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 788,534 | $22,441,000 | 0.93% |
| Rock Springs Capital Management LP | 308,000 | $8,766,000 | 0.71% |
| JUNCTURE WEALTH STRATEGIES, LLC | 18,502 | $527,000 | 0.43% |
| B. Riley Wealth Management, Inc. | 8,600 | $244,000 | 0.35% |